Patents
Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
05/2001
05/22/2001US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis
05/22/2001US6235735 Aftertreatment of radiation therapy
05/17/2001WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/16/2001EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/16/2001EP0839136B1 BENZO[g]QUINOLINE DERIVATIVES
05/15/2001US6232328 Non-systemic control of parasites
05/15/2001US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/15/2001US6232310 Antidiabetic agents
05/15/2001CA2238978C Retroviral protease inhibiting compounds
05/08/2001US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups
05/08/2001US6228878 Administering indolin-5-one derivatives; inhibiting formation of abnormally phosphorylated paired helical filament epitopes
05/02/2001EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
05/02/2001CN1293669A Benzylpiperazingl-and benzylipeeridinyl ethanone derivatives, their preparation method and their use as dopamine D receptor antagonists
05/01/2001US6225334 Glyoxylic acid derivatives
05/01/2001US6225311 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
04/2001
04/24/2001US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
04/24/2001US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase.
04/17/2001US6218544 Heterocyclic esters and amides
04/17/2001US6218359 Treating autoimmune, arthritic, tumor diseases
04/11/2001EP1091211A1 Metal chelate containing compositions for use in chemiluminescent assays
04/11/2001EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion
04/11/2001EP1089964A1 Hydrazine derivatives
04/11/2001CN1064354C Trilcyclic benzazepine vasopressin antagnonists
04/10/2001US6214829 Piperazine compounds, their preparation, and methods of using them
04/05/2001WO2001023497A1 Organic electroluminescent element
04/04/2001CN1289766A Penicillene compounds and derivatives therefrom
04/03/2001US6211240 O-benzyl oxime ether derivatives and their use as pesticides
04/03/2001US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates
04/03/2001CA2102772C Azetidinone compound and process for preparation thereof
03/2001
03/29/2001WO2000075139A3 Benzothiazinone and benzoxazinone compounds
03/28/2001EP1085853A1 Heterocyclic ester and amide hair growth compositions and uses
03/22/2001WO2001019807A1 2-imino-1,3-thiazine derivatives
03/22/2001CA2384757A1 2-imino-1,3-thiazine derivatives
03/20/2001US6204293 Inhibitors of protein isoprenyl transferases
03/15/2001WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase
03/15/2001WO2001017972A2 Novel herbicides
03/15/2001CA2383782A1 Compounds for the treatment of viral infections
03/14/2001EP1082315A1 Potassium channel inhibitors
03/14/2001EP1082313A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
03/13/2001US6200972 Heterocyclic esters and amides
03/13/2001US6200971 For treating atherosclerosis
03/06/2001US6197782 Therapy for sexual disorders
03/06/2001US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
03/01/2001WO2001014371A1 N-heterocyclic derivatives as nos inhibitors
02/2001
02/28/2001EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
02/27/2001US6194573 Oxidizing n,n'-dimethyl-.rho.-phenylenediamine; introducing source of thiosulfate ions; oxidizing and condensing with o-toluidine; oxidizing to cause cyclization to form toluidine blue o; complexing with complexing agent; separation
02/22/2001WO2001012614A1 N-oxyl radicals
02/22/2001WO2001012265A1 Use of cyamemazine for cold turkey benzodiazepine treatment
02/22/2001DE19939031A1 N-Oxyl-Radikale N-oxyl radicals
02/20/2001US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
02/20/2001US6191127 Antiinflammatory agents, autoimmune diseases, cardiovascular disorders, nervous system disorders
02/15/2001WO2000054759A3 Lxr modulators
02/14/2001EP1075465A1 Arylphenyl-substituted cyclic keto enols
02/07/2001EP1073650A1 Guanidine derivatives
02/06/2001US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites
02/06/2001US6184224 Drug resistance and side effect reduction
01/2001
01/31/2001CN1281855A Preparation method of mixture of phenthiazine alkylate and diphenylamine
01/31/2001CN1281854A Benzothiazine derivative
01/30/2001US6180354 Metal chelate containing compositions for use in chemiluminescent assays
01/24/2001CN1281443A Bicyclic compounds, process for their preparation and pharmaceutical composition containing them
01/23/2001US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis
01/17/2001EP1068193A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d 4? receptor antagonists
01/17/2001EP1068191A1 Benzoxazinones/benzothiazinones as serine protease inhibitors
01/17/2001CN1280575A New tricyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
01/17/2001CN1280574A New heterocyclic compounds and their use in medicine, process for their prepartion and pharmaceutical compositions containing them
01/16/2001US6174908 Treating disease, condition, or disorder which responds to inhibition of potassium channel function by administering thiazolidone or metathiazonone compound, its salt, amide, ester, complex, chelate, hydrate, stereoisomer, metabolite
01/10/2001EP1067386A2 Inhibition of tau-tau-association
01/10/2001EP1067124A1 Process for the preparation of a mixture of alkylated phenothiazines and diphenylamines
01/10/2001CN1279669A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
01/09/2001US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same
01/09/2001US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
01/09/2001US6172060 Therapy for sexual disorders
01/09/2001US6171522 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
01/04/2001WO2001000621A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
01/04/2001CA2377154A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
01/03/2001CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals
01/02/2001CA2068064C Fibrinogen receptor antagonists
12/2000
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/26/2000US6166010 For combating animal pests
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/06/2000EP1056717A1 Arylphenyl-substituted cyclic keto-enols
12/06/2000CN1275912A Novel amide derivatives
12/05/2000US6156794 Nervous system disorders or alzheimers disease
11/2000
11/30/2000WO2000071528A1 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
11/30/2000WO2000032583A9 Antitumor dibenzofluorene derivatives
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/28/2000US6153759 Herbicide comprising a 5-membered or 6-membered heterocyclic, saturated or unsaturated radical containing one to three hetero atoms selected from the group consisting of oxygen, sulfur and nitrogen
11/28/2000US6153757 Metalloproteinase inhibitors and intermediates useful for their preparation
11/21/2000US6150370 1,3-dinitrocyclic compound treats numerous diseases caused by undesired metalloprotease activity, such as tumor metastasis, osteoarthritis, rheumatoid arthritis, skin inflammation, ulcerations, and periodontitis
11/15/2000CN1273244A Method for preparing cyclic thioamide compound
11/15/2000CN1058492C Benzothiazine derivative
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066564A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000CA2372279A1 Compositions containing benzimidazolones and progestogens
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 52